Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MEI Pharma Q2 EPS $(0.40) Up From $(1.66) YoY

Author: Benzinga Newsdesk | February 12, 2025 04:39pm
MEI Pharma (NASDAQ:MEIP) reported quarterly losses of $(0.40) per share. This is a 75.9 percent increase over losses of $(1.66) per share from the same period last year.

Posted In: MEIP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist